Evaluation of Cinnamoyl Sulfonamide Hydroxamate Derivatives for their Anticancer Potency Against Squamous Cell Carcinoma

Abstract

newline The metabolic responses exhibited by the substances under investigation are crucial in the up-regulation of both apoptotic and terminal differentiation pathways. The two substances from our investigation, 3a and 3b, were examined for a range of in vitro antioxidant and anti-cancer properties. There was a marginal decrease in cells in G0/G1 phase from 70.4% to 53.1 (%Gated) and increase in cells in S phase from 14.8% to 18.0% (Gated %) and at G2 M phase cells (10.9% to 14.5%) indicative of both late apoptotic and necrotic cell population when compared with untreated control cells suggesting a marginal arrest comparatively lower than Anisidine at S phase. The upregulation of p21 expression was clearly observed among OECM 1, UM-SCC 6, and the HSC-3 cell lines following treatment. This HSC-3 cell line exhibited a band intensity comparable to that of p21 (the control), suggesting a greater degree of cytotoxicity and establishing a connection between DNA as well as cell cycle arrest. P21, an integral component of the cell cycle arrest mechanism and a key target of p53 activity, facilitates apoptosis via pathways that are both p53-dependent and p53-independent. Therefore, rather of causing programmed cell death, or apoptosis, p21 can be understood to highlight the role of the chemicals in controlling or halting the cell cycle. Among these, compound 3a showed good activity, ie., even at lower concentration 3a has a potential effect of 80% equivalent to higher concentration of 3b

Description

Keywords

Citation

item.page.endorsement

item.page.review

item.page.supplemented

item.page.referenced